Cargando…

NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease

Detalles Bibliográficos
Autores principales: Thatcher, Gregory RJ, Luo, Jia, VandeVrede, Lawren, Qin, Zhihui, Lee, Sue, Abdelhamid, Ramy, Bennett, Brian M, Jo LaDu, Mary, Tai, Leon, Larson, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765650/
http://dx.doi.org/10.1186/2050-6511-14-S1-P72
_version_ 1782283359159844864
author Thatcher, Gregory RJ
Luo, Jia
VandeVrede, Lawren
Qin, Zhihui
Lee, Sue
Abdelhamid, Ramy
Bennett, Brian M
Jo LaDu, Mary
Tai, Leon
Larson, John
author_facet Thatcher, Gregory RJ
Luo, Jia
VandeVrede, Lawren
Qin, Zhihui
Lee, Sue
Abdelhamid, Ramy
Bennett, Brian M
Jo LaDu, Mary
Tai, Leon
Larson, John
author_sort Thatcher, Gregory RJ
collection PubMed
description
format Online
Article
Text
id pubmed-3765650
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37656502013-09-11 NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease Thatcher, Gregory RJ Luo, Jia VandeVrede, Lawren Qin, Zhihui Lee, Sue Abdelhamid, Ramy Bennett, Brian M Jo LaDu, Mary Tai, Leon Larson, John BMC Pharmacol Toxicol Poster Presentation BioMed Central 2013-08-29 /pmc/articles/PMC3765650/ http://dx.doi.org/10.1186/2050-6511-14-S1-P72 Text en Copyright © 2013 Thatcher et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Thatcher, Gregory RJ
Luo, Jia
VandeVrede, Lawren
Qin, Zhihui
Lee, Sue
Abdelhamid, Ramy
Bennett, Brian M
Jo LaDu, Mary
Tai, Leon
Larson, John
NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease
title NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease
title_full NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease
title_fullStr NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease
title_full_unstemmed NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease
title_short NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease
title_sort no/cgmp/pcreb re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of alzheimer’s disease
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765650/
http://dx.doi.org/10.1186/2050-6511-14-S1-P72
work_keys_str_mv AT thatchergregoryrj nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease
AT luojia nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease
AT vandevredelawren nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease
AT qinzhihui nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease
AT leesue nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease
AT abdelhamidramy nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease
AT bennettbrianm nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease
AT joladumary nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease
AT taileon nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease
AT larsonjohn nocgmppcrebreactivationreversescognitiondeficitsandattenuatesamyloidbneuropathologyintransgenicmodelsofalzheimersdisease